There has been suggestions that activation of P2Y2 and P2Y4 receptors may be useful in treating neurodegenerative diseases.18,221 Studies of rat primary cerebellar neurons has provided evidence that P2Y13 receptor activation protected neurons against oxidative stress-induced death.236 P2Y1 receptor has specifically emerged as a new target for treating cognitive dysfunction in CNS.226,237,238
